SAR445399 Clinical Trials (2026): 2 Studies for Hidradenitis Suppurativa & Non-cystic Fibrosis Bronchiectasis
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 SAR445399 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Hidradenitis Suppurativa & Non-cystic Fibrosis Bronchiectasis) and 214 total planned enrollment. 2 SAR445399 clinical trials are actively recruiting at 19 U.S. sites across 9 states. Most recent activity: NCT07547436 (Aug 2028).
Where to Participate: All SAR445399 Trial Sites in the U.S. (19 sites across 9 states)
Every actively recruiting SAR445399trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AZ | Scottsdale Clinical Trials- Site Number : 8400006 | Scottsdale85260 | NCT07225569 | Map |
| CA | Carbon Health - North Hollywood - NoHo West- Site Number : 8400017 | North Hollywood91606 | NCT07225569 | Map |
| FL | Encore Medical Research of Boynton Beach- Site Number : 8400005 | Boynton Beach33436 | NCT07225569 | Map |
| FL | FXM Clinical Research - Fort Lauderdale- Site Number : 8400013 | Fort Lauderdale33308 | NCT07225569 | Map |
| FL | Alliance for Multispeciality Research - Fort Myers- Site Number : 8400007 | Fort Myers33912 | NCT07225569 | Map |
| FL | Encore Medical Research - Hollywood- Site Number : 8400004 | Hollywood33024 | NCT07225569 | Map |
| FL | Advanced Pulmonary Research Institute- Site Number : 8400001 | Loxahatchee Groves33470 | NCT07547436 | Map |
| FL | Florida International Research Center- Site Number : 8400002 | Miami33173 | NCT07225569 | Map |
| FL | Florida Research Center- Site Number : 8400009 | Miami33174 | NCT07225569 | Map |
| FL | Fxm Clinical Research/Fax Pharma Clinical Research- Site Number : 8400014 | Miami33146 | NCT07225569 | Map |
| FL | Hull and Hull Medical Specialists- Site Number : 8400002 | Plantation33324 | NCT07547436 | Map |
| FL | Advanced Clinical Research Institute- Site Number : 8400021 | Tampa33607 | NCT07225569 | Map |
| GA | Cleaver Medical Group Dermatology- Site Number : 8400008 | Cumming30040 | NCT07225569 | Map |
| GA | First Georgia Physician Group- Site Number : 8400033 | Fayetteville30214 | NCT07225569 | Map |
| KS | Essential Medical Research- Site Number : 8400015 | Overland Park66213 | NCT07225569 | Map |
| KY | Dermatology Specialists Research (DS Research) - Kentucky- Site Number : 8400026 | Louisville40241 | NCT07225569 | Map |
| NY | Equity Medical- Site Number : 8400010 | New York10023 | NCT07225569 | Map |
| PA | Clinical Research Associates of Central Pennsylvania- Site Number : 8400006 | DuBois15801 | NCT07547436 | Map |
| TX | Elligo Health Research/The Woodlands Dermatology Associates- Site Number : 8400020 | The Woodlands77380 | NCT07225569 | Map |
SAR445399 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P2 | 2 | 2 |
Recruiting SAR445399 clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07547436 | A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis | P2 | Non-cystic Fibrosis Bronchiectasis | 70 | Jun 2026 |
| NCT07225569 | CLAROSA Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa | P2 | Hidradenitis Suppurativa | 144 | Dec 2025 |
SAR445399 clinical trials by indication
Non-cystic Fibrosis Bronchiectasis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07547436 | — | P2 | recruiting | A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis |
Hidradenitis Suppurativa (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07225569 | CLAROS | P2 | recruiting | A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa |
SAR445399 pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| CLAROS | NCT07225569 | P2 | recruiting | Hidradenitis Suppurativa | 144 | — |
All SAR445399 trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07547436 | A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis | P2 | recruiting | 70 | Sanofi | Jun 2026 | |
| NCT07225569 | CLAROS | A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa | P2 | recruiting | 144 | Sanofi | Dec 2025 |
SAR445399 clinical trials: frequently asked questions
- How many SAR445399 clinical trials are there?
- 2 SAR445399 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants.
- Are SAR445399 clinical trials recruiting in 2026?
- Yes — 2 SAR445399 trials are actively recruiting in 2026, with 19 U.S. sites across 9 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is SAR445399 being studied for?
- SAR445399 is being studied for Hidradenitis Suppurativa, Non-cystic Fibrosis Bronchiectasis. The trials are grouped by indication on this page.
- What phase is SAR445399 in?
- SAR445399 clinical trials span 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors SAR445399 clinical trials?
- The lead sponsor across the most SAR445399 trials is Sanofi. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming SAR445399as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: